Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in raw 264.7 cells

Journal of Immunology

Volumn 173, Issue 11, 2004, Pages 6973-6980

  Woo, Chang Hoon ^a   Lim, Jae Hyang ^a,b   Kim, Jae Hong ^a  

^a Korea University   (South Korea)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DIPHENYLIODONIUM SALT; ENDOTOXIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MUTANT PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C DELTA; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; ROTENONE; ROTTLERIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; DOWN REGULATION; MACROPHAGE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 9144234780     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.11.6973     Document Type: Article

References (64)

1. Coussens, L. M., B. Fingleton, and L. M. Matrisian. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387.
2. Ellerbroek, S. M., and M. S. Stack. 1999. Membrane associated matrix metalloproteinases in metastasis. BioEssays 21:940.
3. Brinckerhoff, C. E., and L. M. Matrisian. 2002. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3:207.
4. Vihinen, P., and V. M. Kahari. 2002. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer 99:157.
5. Westermarck, J., and V. M. Kahari. 1999. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:781.
6. Visse, R., and H. Nagasse. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92:827.
7. Hoshino, M., Y. Nakamura, J. Sim, J. Shimojo, and S. Isogai. 1998. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J. Allergy Clin. Immunol. 102:783.
8. Curry, T. E., Jr., and K. G. Osteen. 2003. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 24:428.
9. Sato, H., and M. Seiki. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395.
10. Gum, R., M. Lengyel, J. Juarez, J. H. Chen, H. Sato, M. Seiki, and D. Boyd. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271:10672.
11. Sen, C. K., and L. Packer. 1996. Antioxidant and redox regulation of gene transcription. FASEB J. 10:709.
12. Rhee, S. G. 1999. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31:53.
13. Bowie, A., and L. A. O'Neill. 2000. Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59:13.
14. Quillet-Mary, A., J. Jaffrézou, V. Mansat, C. Bordier, J. Naval, and G. Laurent. 1997. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J. Biol. Chem. 272:21388.
15. Hancock, J. T., and C. T. Jones. 1987. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem. J. 242: 103.
16. Li, Y., and M. A. Trush. 1998. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun. 253:295.
17. Haddad, J. J. 2002. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell. Signal. 14:879.
18. Dumont, A., S. P. Hehner, T. G. Hofmann, M. Ueffing, W. Droge, and M. L. Schmitz. 1999. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB. Oncogene 18:747.
19. 2 sensing. J. Biol. Chem. 275:25130.
20. Hsieh, T. J., S. L. Zhang, J. G. Filep, S. S. Tang, J. R. Ingelfinger, and J. S. D. Chan. 2002. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143:2975.
21. Martiny-Baron, G., M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, D. Marme, and C. Schachtele. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö6973. J. Biol. Chem. 268:9194.
22. Gschwendt, M., H. J. Muller, K. Kielbassa, R. Zang, W. Kittstein, G. Rincke, and F. Marks F. 1994. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199:93.
23. Jarvis, W. D., A. J. Turner, L. F. Povirk, R. S. Traylor, and S. Grant. 1994. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54:1707.
24. Means, T. K., R. P. Pavlovich, D. Roca, M. W. Vermeulen, and M. J. Fenton. 2000. Activation of TNF-α transcription utilizes distinct MAP kinase pathways in different macrophage populations. J. Leukocyte Biol. 67:885.
25. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interlukin-1. FEBS Lett. 364:229.
26. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98:13681.
27. Schreck, R., B. Meier, D. N. Männel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181.
28. 3H] Dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study. J. Neurosci. 16:3807.
29. 4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade. J. Immunol. 170:6273.
30. 2-linked cascade. J. Biol. Chem. 275:32357.
31. Genersch, E., K. Hayess, Y. Neuenfeld, and H. Haller. 2000. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci. 113 Pt. 23:4319.
32. Simon, C., H. Goepfert, and D. Boyd. 1998. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58:1135.
33. Braiman, L., A. Alt, T. Kuroki, M. Ohba, A. Bak, T. Tennenbaum, and S. R. Sampson. 1999. Protein kinase C-δ mediates insulin-induced glucose transport in primary cultures of rat skeletal muscle. Mol. Endocrinol. 13:2002.
34. Soltoff, S. P. 2001. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase C-δ tyrosine phosphorylation. J. Biol. Chem. 276:37986.
35. Kayali, A. G., D. A. Austin, and N. J. Webster. 2002. Rottlerin inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes by uncoupling mitochondrial oxidative phosphorylation. Endocrinology 143:3884.
36. Tillman, D. M., K. Izeradjene, K. S. Szucs, L. Douglas, and J. A. Houghton. 2003. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res. 63:5118.
37. Holland, P. C., M. G. Clark, D. P. Bloxham, and H. A. Lardy. 1973. Mechanism of action of the hypoglycemic agent diphenyleneiodonium. J. Biol. Chem. 248:6050.
38. Parthasarathi, K., H. Ichimura, S. Quadri, A. Issekutz, and J. Bhattacharya. 2002. Mitochondrial reactive oxygen species regulate spatial profile of proinflammatory responses in lung venular capillaries. J. Immunol. 169:7078.
39. Deshpande, S. S., P. Angkeow, J. Huang, M. Ozaki, and K. Irani. 2000. Rac1 inhibils TNF-α-induced endothelial cell apoplosis: dual regulation by reactive oxygen species. FASEB J. 14:1705.
40. Fenton, M. J., and D. T. Golenbock. 1998. LPS-binding proteins and receptors. J. Leukocyte Biol. 64:25.
41. Morrison, D. C., and R. J. Ulevitch. 1978. The effects of bacterial endotoxins on host mediation systems. Am. J. Pathol. 93:526.
42. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 395:284.
43. Wong, P. M. C., S. W. Chung, and B. M. Sultzer. 2000. Genes, receptors, signals and responses to lipopolysaccharide endotoxin. Scand. J. Immunol. 51:123.
44. i2, in the promonocytic cell line U937. J. Biol. Chem. 264:20240.
45. Chen, T. Y., M. G. Lei, T. Suzuki, and D. C. Morrison. 1992. Lipopolysaccharide receptors and signal transduction pathways in mononuclear phagocytes. Curr. Top. Microbiol. Immunol. 181:169.
46. Shapira, L., S. Takashiba, C. Champagne, S. Amar, and T. E. Van Dyke. 1994. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-α and IL-1β production by human monocytes. J. Immunol. 153:1818.
47. 2 production in lipopolysaccharide-stimulated monocytes. J. Immunol. 161:5681.
48. Lee, W. J., C. Y. Shin, B. K. Yoo, J. R. Ryu, E. Y. Choi, J. H. Cheong, J. H. Ryu, and K. H. Ko. 2003. Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 41:15.
49. Underwood, D. C., R. R. Osborn, S. Bochnowicz, E. F. Webb, D. J. Rieman, J. C. Lee, A. M. Romanic, J. L. Adams, D. W. Hay, and D. E. Griswold. 2000. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am. J. Physiol. 279:1895.
50. Lai, W. C., M. Zhou, U. Shankavaram, G. Peng, and L. M. Wahl. 2003. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol. 170:6244.
51. Sano, M., K. Fukuda, T. Sato, H. Kawaguchi, M. Suematsu, S. Matsuda, S. Koyasu, H. Matsui, K. Yamauchi-Takihara, M. Harada, et al. 2001. ERK and p38 MAPK, but not NF-κB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ. Res. 89:661.
52. Herrera, B., M. Fernandez, C. Roncero, J. J. Ventura, A. Porras, A. Valladares, M. Benito, and I. Fabregat. 2001. Activation of p38 MAPK by TGF-β in fetal rat hepatocytes requires radical oxygen production, but is dispensable for cell death. FEBS Lett. 499:225.
53. Hashimoto, S., Y. Gon, K. Matsumoto, I. Takeshita, and T. Horie. 2001. N-acetylcysteine attenuates TNF-α-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br. J. Pharmacol. 132:270.
54. Dabrowski, A., C. Boguslowicz, M. Dabrowska, I. Tribillo, and A. Gabryelewicz. 2000. Reactive oxygen species activate mitogen-activated protein kinases in pancreatic acinar cells. Pancreas 21:376.
55. Kulisz, A., N. Chen, N. S. Chandel, Z. Shao, P. T. Schumacker. 2000. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 282:11324.
56. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129.
57. Cao, J., A. Rehemtulla, W. Bahou, and S. Zucker. 1996. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J. Biol. Chem. 271:30174.
58. Tomasek, J. J., N. L. Halliday, D. L. Updike, J. S. Ahem-Moore, T. K. Vu, R. W. Liu, and E. W. Howard. 1997. Gelatinase activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem. 272:7482.
59. Matrisian, L. M. 1994. Matrix metalloproteinase gene expression. Ann. NY Acad. Sci. 732:42.
60. Yoo, H. G., B. A. Shin, J. S. Park, K. H. Lee, K. O. Chay, S. Y. Yang, B. W. Ahn, and Y. D. Jung. 2002. IL-1β induces MMP-9 via reactive oxygen species and NF-κB in murine macrophage RAW 264.7 cells. Biochem. Biophys. Res. Commun. 298:251.
61. 2 as a trigger and NF-κB as a signal transducer. Thromb. Haemost. 90:528.
62. Moon, S. K., B. Y. Cha, and C. H. Kim. 2004. ERK1/2 mediates TNF-α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: involvement of the ras dependent pathway. J. Cell Physiol. 198:417.
63. Hah, N., and S. T. Lee. 2003. An absolute role of the PKC-dependem NF-κB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 305:428.
64. Simon, C., M. Simon, G. Vucelic, M. J. Hicks, P. K. Plinkert, A. Koitschev, and H. P. Zenner. 2001. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res. 271:344.